Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on shared a post on X:
”A joy to listen to Dr. Martin Reck recount the history of immunotherapy in NSCLC from 2L to our 1L standard. Long term survival now achievable for some.
Unanswered questions remain, including the role of chemo for PDL1 high but awaiting INSIGNA data.”
Other Articles Featuring Stephen V Liu On OncoDaily.
